tiprankstipranks
Advertisement
Advertisement

Global Health Reports No Demat or Remat Activity for March Quarter

Story Highlights
  • Global Health Limited received its SEBI Regulation 74(5) quarterly compliance certificate from Kfin Technologies.
  • The registrar confirmed no securities were dematerialized or rematerialized in the March 2026 quarter, signaling a stable shareholding structure.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Global Health Reports No Demat or Remat Activity for March Quarter

Claim 55% Off TipRanks

Global Health Limited ( (IN:MEDANTA) ) has issued an update.

Global Health Limited has notified the stock exchanges that it has obtained the required quarterly certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 from its registrar and transfer agent, Kfin Technologies Limited. The registrar confirmed that there were no securities dematerialized or rematerialized during the quarter ended March 31, 2026, indicating stability in the company’s shareholding structure and no changes in the form of its listed securities for that period.

More about Global Health Limited

Global Health Limited, which operates under the Medanta brand, is a healthcare company based in New Delhi, focusing on hospital and medical services. The company is listed on both BSE and NSE under the symbol MEDANTA, and utilizes Kfin Technologies Limited as its registrar and transfer agent for managing its securities-related activities.

Average Trading Volume: 26,869

Technical Sentiment Signal: Sell

Current Market Cap: 266.1B INR

For detailed information about MEDANTA stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1